David Walton
Corporate Officer/Principal at LUMIRADX LIMITED
Net worth: 56 834 $ as of 30/12/2023
Profile
David Walton is currently the Chief Commercial Officer at LumiraDx Ltd.
(Cayman Islands) and LumiraDX Ltd.
He previously worked as the International Director-Consumer Business Unit at Unipath Ltd., Director at Abbott Diagnostics Korea, Inc., and President-Asia Pacific at Alere, Inc. He also served as Vice President-International Business at Unilever Plc.
Dr. Walton received his undergraduate degree from The University of Manchester and his doctorate from the University of London.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
LUMIRADX LIMITED
0.43% | 30/12/2022 | 902,122 ( 0.43% ) | 56 834 $ | 30/12/2023 |
LUMIRADX LIMITED
-.--% | 30/12/2022 | 0 ( -.--% ) | - $ | 30/03/2024 |
David Walton active positions
Companies | Position | Start |
---|---|---|
LUMIRADX LIMITED | Corporate Officer/Principal | 31/07/2014 |
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands. | Corporate Officer/Principal | 31/07/2014 |
Former positions of David Walton
Companies | Position | End |
---|---|---|
ALERE INC | Corporate Officer/Principal | 31/08/2014 |
UNILEVER PLC | Corporate Officer/Principal | 31/12/2006 |
Abbott Diagnostics Korea, Inc.
Abbott Diagnostics Korea, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics Korea, Inc. develops diagnostic systems for the detection of infectious diseases. Its products include rapid test kits, human immunodeficiency virus rapid test kits, blood glucose test kits, urine test kits, dengue and rapid dengue test kits, malaria rapid test kits and various forms of enzyme-linked immunosorbent assay kits. The company was founded on February 1, 1999 and is headquartered in Yongin, South Korea. | Director/Board Member | - |
Unipath Ltd.
Unipath Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Unipath Ltd. is a British company that manufactures female healthcare products. The private company is based in Bedford, UK. The company was founded in 1946 by Paul James Davis. Unipath was acquired by Alere, Inc. from Unilever NV on December 20, 2001 for $146.54 million. | Corporate Officer/Principal | - |
Training of David Walton
The University of Manchester | Undergraduate Degree |
University of London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
UNILEVER PLC | Consumer Non-Durables |
LUMIRADX LIMITED | Health Technology |
Private companies | 4 |
---|---|
Alere, Inc.
Alere, Inc. Medical SpecialtiesHealth Technology Alere, Inc. engages in developing, manufacturing, and marketing consumer and professional medical diagnostic products. It operates through the following segments: Professional Diagnostics, Consumer Diagnostics, and Other Non-Reportable. The Professional Diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests. The Consumer Diagnostics segment consists of manufacturing operations. The Other Non-Reportable segment includes Alere Home Monitoring, which distributes PT and INR coagulation; monitors and facilitates the distribution of equipment; and supplies to power and control customers' implanted ventricular assist devices and VADs. It also provides telemonitoring services that allow VAD coordinators to monitor patients soon after discharge and receive alerts when critical patient values fall outside pre-established ranges. The company was founded by Ronald Zwanziger on May 11, 2001 and is headquartered in Abbott Park, IL. | Health Technology |
Unipath Ltd.
Unipath Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Unipath Ltd. is a British company that manufactures female healthcare products. The private company is based in Bedford, UK. The company was founded in 1946 by Paul James Davis. Unipath was acquired by Alere, Inc. from Unilever NV on December 20, 2001 for $146.54 million. | Health Technology |
Abbott Diagnostics Korea, Inc.
Abbott Diagnostics Korea, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics Korea, Inc. develops diagnostic systems for the detection of infectious diseases. Its products include rapid test kits, human immunodeficiency virus rapid test kits, blood glucose test kits, urine test kits, dengue and rapid dengue test kits, malaria rapid test kits and various forms of enzyme-linked immunosorbent assay kits. The company was founded on February 1, 1999 and is headquartered in Yongin, South Korea. | Health Technology |
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands. | Health Technology |
- Stock Market
- Insiders
- David Walton